Sign In
Buy MRSN
$29.08
+0 (+0%)
At Close: Apr 02, 2026
The Zacks Analyst Blog Highlights: Aileron Therapeutics, Energy Focus, MicroVision, Mersana Therapeutics and CymaBay Therapeutics
02:22pm, Tuesday, 02'nd Jun 2020
The Zacks Analyst Blog Highlights: Aileron Therapeutics, Energy Focus, MicroVision, Mersana Therapeutics and CymaBay Therapeutics
Bridgewater's Adult Day Center Holds Drive-By Parade
12:28am, Tuesday, 02'nd Jun 2020
The Adult Day Center of Somerset County celebrated National Road Trip Day on Friday, May 22 with a drive-by parade to its members' homes.
5 Top Stocks Up 100%+ in May With More Room to Run
12:34pm, Monday, 01'st Jun 2020
Reopening of the economy, vaccine hopes and stimulus measures helped Wall Street climb north in May and squash the old adage "sell in May and go away."
Competition heats up in BCMA CAR-T as J&J, BMS update myeloma trials -
12:19pm, Saturday, 30'th May 2020
Competition heats up in BCMA CAR-T therapy as J&J, BMS update multiple myeloma trials at ASCO20
Notable Insider Buys: Avis, Dynavax And Formula One
12:00am, Saturday, 30'th May 2020
Insider buying can be an encouraging signal for potential investors.
Beneficial owner Berkshire Hathaway made a huge purchase last week.
A director took advantage of a...
Mersana Therapeutics (MRSN) in Focus: Stock Moves 8.3% Higher
02:29pm, Friday, 29'th May 2020
Mersana Therapeutics (MRSN) saw a big move last session, as its shares jumped more than 8% on the day, amid huge volumes.
Mersana Therapeutics Announces Pricing of Public Offering of Common Stock
03:25am, Friday, 29'th May 2020
Mersana Therapeutics, Inc. (MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates (ADCs) targeting cancers in areas of high unm
MRSN, PAAS, WORK, ZYXI — Stock Charts To Watch
12:00am, Friday, 29'th May 2020
Stocks Analysis by Harry Boxer covering: Bed Bath & Beyond Inc, Ballard Power Systems Inc, Allegheny Technologies Incorporated, Apache Corporation. Read Harry Boxer's latest article on Investing.com
Mersana Therapeutics to Present at Jefferies Virtual Global Healthcare Conference
09:00pm, Thursday, 28'th May 2020
CAMBRIDGE, Mass., May 28, 2020 -- Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of.
Company News for May 28, 2020
02:04pm, Thursday, 28'th May 2020
Companies In The News Are:
Mersana Stock Spikes on Interim Data on Cancer Candidate
01:42pm, Thursday, 28'th May 2020
Mersana's (MRSN) antibody-drug conjugate candidate, XMT-1536, achieves encouraging response rate in interim analysis of a phase I study in ovarian cancer patients.
Why Mersana Therapeutics (MRSN) Stock Might be a Great Pick?
12:55pm, Thursday, 28'th May 2020
Mersana Therapeutics (MRSN) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Immunomedics to Participate in Upcoming Healthcare Conferences
12:00pm, Thursday, 28'th May 2020
Immunomedics, Inc. (NASDAQ: IMMU) (“Immunomedics” or the “Company”), a leading biopharmaceutical company in the area of antibody-drug conjugates, today
Mersana Therapeutics Announces Proposed Public Offering of Common Stock
10:00am, Thursday, 28'th May 2020
Mersana Therapeutics, Inc. (MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody drug conjugates (ADCs) targeting cancers in areas of high unm
The French competition authority (ADC) has launched a public consultation on the Fintech industry in the country. The ADC is looking for feedback on the potenti
